下载App
扫码立即下载
  • 下载App

    扫码立即下载

  • 在线客服

    登录后咨询在线客服
+
恭喜您!
成功领取价值超 5000港元/年的高级行情
前往体验 >>
公司概况 更多
杭州启明医疗器械股份有限公司是一家从事用于治疗心脏瓣膜疾病的微创医疗设备以及辅助仪器和设备的研发、制造和销售的中国公司。该公司的主要产品包括VenusA-Valve系统,VenusA-Plus系统,VenusA-Pilot系统,VenusP-Valve系统,TMVR瓣膜, TTVR瓣膜,瓣膜成形术球囊V8/TAV8及TriGUARD3脑栓塞保护仪器。
董事长: 曾敏
所属市场: 香港主板
上市日期: 2019/12/10
富途热股榜
港股美股沪深
交易热度搜索热度资讯热度
名称代码最新价涨跌幅

加载中...

自选
02500 启明医疗-B
11.880+0.320+2.77%
显示同比
不显示
隐藏空行
(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30
Cash flow from operating activities
Earning before tax
-103.16% -3.78亿 -169.27% -1.17亿 51.29% -1.86亿 76.57% -4,352.9万
Profit adjustment
Interest (income) - adjustment
3.71% -3,338万 -24.61% -2,410.5万 -462.5% -3,466.7万 -11346.75% -1,934.5万
Attributable subsidiary (profit) loss
2154.56% 1,171.1万 2361.51% 652.3万 -- -57万 -- 26.5万
Impairment and provisions:
9557.19% 2.38亿 50.77% 392.6万 -10.93% 246.2万 134.81% 260.4万
-Impairmen of inventory (reversal)
-157.09% -143.4万 -55.83% 73.1万 324.32% 251.2万 -- 165.5万
-Impairment of trade receivables (reversal)
6196% 304.8万 236.67% 319.5万 -102.3% -5万 -14.43% 94.9万
-Impairment of goodwill
-- 1.9亿 -- -- -- -- -- --
-Other impairments and provisions
-- 4,618.9万 -- -- -- -- -- --
Revaluation surplus:
-464.41% -2.49亿 -- -1,001.4万 -- -4,412.8万 -- 0
-Derivative financial instruments fair value (increase)
77.31% -1,001.4万 -- -1,001.4万 -- -4,412.8万 -- --
-Other fair value changes
-- -2.39亿 -- -- -- -- -- --
Asset sale loss (gain):
-96.79% 1.8万 -98.56% 8,000 1500% 56万 2826.32% 55.6万
-Loss (gain) on sale of property, machinery and equipment
-96.79% 1.8万 -98.56% 8,000 1500% 56万 2826.32% 55.6万
Depreciation and amortization:
36.88% 5,162.1万 22.27% 2,183.7万 30.46% 3,771.2万 35.34% 1,786万
-Depreciation
39.44% 2,916.9万 11.08% 1,219.4万 31.37% 2,091.8万 61.06% 1,097.8万
-Amortization of intangible assets
33.69% 2,245.2万 40.12% 964.3万 29.35% 1,679.4万 7.87% 688.2万
Financial expense
-54.34% 190.5万 -67.99% 98.4万 -80.97% 417.2万 -69.44% 307.4万
Special items
-71.99% 2,691.4万 206.89% 1,859.3万 -12.12% 9,607.2万 -129.31% -1,739.4万
Operating profit before the change of operating capital
-165.69% -3.3亿 -77.89% -9,945.9万 44.73% -1.24亿 45.3% -5,590.9万
Change of operating capital
Inventory (increase) decrease
22.45% -2,918.1万 52.25% -703.6万 -332.69% -3,762.7万 -1236.96% -1,473.5万
Accounts receivable (increase)decrease
-34.77% -9,542.4万 -8213.89% -1.38亿 18.71% -7,080.4万 97.19% -166.3万
Accounts payable increase (decrease)
77.79% -509.7万 120.16% 1,172.1万 -208.95% -2,295万 -1168.84% -5,813.4万
prepayments (increase)decrease
-4448.36% -1,726.3万 -11.94% -463.1万 103.68% 39.7万 61.91% -413.7万
Cash  from business operations
-80.61% -4.77亿 -70.02% -2.3亿 12.61% -2.64亿 15.01% -1.35亿
Other taxs
-57.96% -864.5万 79.93% -86.3万 -9.39% -547.3万 -148.35% -429.9万
Interest received - operating
-11.95% 2,864.3万 31.45% 2,410.5万 739.27% 3,253万 10750.89% 1,833.8万
Special items of business
101.33% 11.8万 2047.13% 813.9万 -208.84% -884.8万 -106.34% -41.8万
Net cash from operations
-92.79% -4.57亿 -70.54% -2.06亿 21.86% -2.37亿 24.59% -1.21亿
Cash flow from investment activities
Interest received - investment
-- 1,500万 -- -- -- -- -- --
Sale of fixed assets
-- -- -- -- 966.67% 3.2万 -- 3.2万
Purchase of fixed assets
-64.86% -8,207万 -74.92% -2,366.1万 -216.9% -4,978.2万 -202.28% -1,352.7万
Purchase of intangible assets
73.47% -1,970.5万 64.1% -278.2万 -742.01% -7,426.5万 -1094.14% -775万
Acquisition of subsidiaries
-128.15% -1.25亿 -- -- -747.59% -5,461万 -747.59% -5,461万
Recovery of cash from investments
-- 5,414.2万 -- 5,414.2万 -- -- -- --
Cash on investment
-623.09% -4.57亿 -184.1% -8,104.1万 -- -6,316.3万 -- -2,852.6万
Other items in the investment business
30.4% -3,908.6万 45.59% -5,785.3万 -- -5,615.5万 -- -1.06亿
Net cash from investment operations
-119.18% -6.53亿 47.23% -1.11亿 -862.07% -2.98亿 -1721.6% -2.11亿
Net cash before financing
-107.49% -11.1亿 4.28% -3.17亿 -60.04% -5.35亿 -92.87% -3.32亿
Cash flow from financing activities
New borrowing
-- -- -- -- -- -- -99.08% 98.5万
Refund
96.08% -470万 -- -- -79.71% -1.2亿 -300% -1.2亿
Issuing shares
15.18% 11.91亿 -- 11.91亿 -61.39% 10.34亿 -- --
Interest paid - financing
81.07% -12.7万 30.16% -98.4万 92.53% -67.1万 67.6% -140.9万
Absorb investment income
112.5% 4,250万 -- 2,250万 -93.52% 2,000万 -- --
Issuance expenses and redemption of securities expenses
-- -7,254.8万 -- -- -- -- -- --
Other items of the financing business
4093.61% 2.35亿 -1206.02% -936.8万 97.95% -588.3万 118.09% 84.7万
Net cash from financing operations
49.98% 13.91亿 1106.45% 12.03亿 -64% 9.28亿 -131.75% -1.2亿
Effect of rate
64.85% -3,440.4万 -268.54% -1,439.7万 -1966.29% -9,788.7万 804.87% 854.2万
Net Cash
-28.35% 2.81亿 296.35% 8.86亿 -82.49% 3.93亿 -320.46% -4.51亿
Begining period cash
12.22% 27.08亿 12.22% 27.08亿 1363.34% 24.13亿 1363.34% 24.13亿
Cash at the end
9.12% 29.55亿 81.66% 35.8亿 12.22% 27.08亿 431.81% 19.71亿
Cash balance analysis
Cash and cash equivalent balance
-- 0 -- 0 -- 0 -- 0
Currency Unit
人民币人民币人民币人民币
Accounting Standards
国际会计准则国际会计准则国际会计准则国际会计准则
Audit Opinions
无保留意见--无保留意见--
Auditor
安永会计师事务所--安永会计师事务所--

Q6、Q9、FY为累计季报:Q6 为中期报告;Q9 为第三季报;FY为年报。

环比数据来源于季报,环比 = (本期 - 上期)/上期 * 100%

回到顶部